Skip to main content
European Commission logo print header

Molecular characterization and identification of biological risk factors in mantle cell lymphoma


In the previous Biomed II program, a European concerted action of clinicians and pathologists has been established, to define the clinical characteristics as well as the precise morphological criteria for the sub classification of MCL. Based on this established European infrastructure, we are planning to extend our focus of research to the basic molecular risk factors in MCL. This research network is structured into 4 differentially focussed work packages, each of tem representing an international collaboration of several research groups:
(1) primary genetic alterations and markers of maturation
(2) Cell cycle deregulation in MCL
(3) Secondary alterations and sequential analysis in MCL
(4) Functional studies of MCL.
This approach will identify high-risk patients and finally direct the development of future innovative treatment options.

Call for proposal

Data not available


Marchioninistr. 15
81377 Muenchen

See on map

EU contribution
€ 0,00

Participants (13)